Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Divergent requirement for Gαs and cAMP in the differentiation and inflammatory profile of distinct mouse Th subsets
Xiangli Li, … , Paul A. Insel, Eyal Raz
Xiangli Li, … , Paul A. Insel, Eyal Raz
Published February 13, 2012
Citation Information: J Clin Invest. 2012;122(3):963-973. https://doi.org/10.1172/JCI59097.
View: Text | PDF
Research Article Immunology

Divergent requirement for Gαs and cAMP in the differentiation and inflammatory profile of distinct mouse Th subsets

  • Text
  • PDF
Abstract

cAMP, the intracellular signaling molecule produced in response to GPCR signaling, has long been recognized as an immunosuppressive agent that inhibits T cell receptor activation and T cell function. However, recent studies show that cAMP also promotes T cell–mediated immunity. Central to cAMP production downstream of GPCR activation is the trimeric G protein Gs. In order to reconcile the reports of divergent effects of cAMP in T cells and to define the direct effect of cAMP in T cells, we engineered mice in which the stimulatory Gα subunit of Gs (Gαs) could be deleted in T cells using CD4-Cre (GnasΔCD4). GnasΔCD4 CD4+ T cells had reduced cAMP accumulation and Ca2+ influx. In vitro and in vivo, GnasΔCD4 CD4+ T cells displayed impaired differentiation to specific Th subsets: Th17 and Th1 cells were reduced or absent, but Th2 and regulatory T cells were unaffected. Furthermore, GnasΔCD4 CD4+ T cells failed to provoke colitis in an adoptive transfer model, indicating reduced inflammatory function. Restoration of cAMP levels rescued the impaired phenotype of GnasΔCD4 CD4+ T cells, reinstated the PKA-dependent influx of Ca2+, and enhanced the ability of these cells to induce colitis. Our findings thus define an important role for cAMP in the differentiation of Th subsets and their subsequent inflammatory responses, and provide evidence that altering cAMP levels in CD4+ T cells could provide an immunomodulatory approach targeting specific Th subsets.

Authors

Xiangli Li, Fiona Murray, Naoki Koide, Jonathan Goldstone, Sara M. Dann, Jianzhong Chen, Samuel Bertin, Guo Fu, Lee S. Weinstein, Min Chen, Maripat Corr, Lars Eckmann, Paul A. Insel, Eyal Raz

×

Figure 8

cAMP enhances the colitogenicity of in vitro differentiated Th17 cells.

Options: View larger image (or click on image) Download as PowerPoint
cAMP enhances the colitogenicity of in vitro differentiated Th17 cells.
...
FACS-sorted naive CD4+ T cells from WT spleens were cultured for 4 days under Th17 differentiation conditions (IL-6/TGF-β) with or without 8Br-cAMP (25 μM) and then adoptively transferred into Rag1–/– mice. (A) Intracellular expression of IFN-γ and IL-17A in Th17 cells before transfer. (B) Percentage of initial body weight of Rag1–/– recipients after transfer of Th17 cells (differentiated in vitro with or without 8Br-cAMP). The co-transfer of WT CD4+CD45RBhiCD25– T cells with CD45RBloCD25+ Tregs was used as control. Data are shown as mean ± SEM; n = 3–5; ***P < 0.001, 2-way ANOVA, recipients receiving in vitro differentiated Th17 cells with or without 8Br-cAMP. (C) Intracellular expression of IFN-γ and IL-17A in Th17 cells 28 days after transfer. CD4+ cells from spleen or MLN of recipient mice at day 28 after transfer were stimulated with PMA/ionomycin for 4 hours, and the intracellular cytokine levels were determined by flow cytometry. The number in each quadrant (A and C) indicates the frequency of cells. (D) Histological analysis of the colons of Rag1–/– mice receiving in vitro differentiated Th17 cells with or without 8Br-cAMP (original magnification, ×100, scale bars: 100 μM).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts